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ALF = acute liver failure; ICU = intensive care unit; NAC = N-acetylcysteine PT = prothrombin time.
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Acetaminophen poisoning is common. In the UK 50% of
poisoning admissions involve acetaminophen; this figure is
nearer 10% in the USA [1,2]. Acetaminophen poisoning can
result from deliberate or accidental/staggered ingestion. The
present commentary discusses the differences in
management of these two presentations, and management of
patients with established hepatotoxicity who require ICU
admission.
Management of early, nonstaggered
acetaminophen poisoning
The antidote for acetaminophen poisoning is N-acetylcysteine
(NAC). It provides complete protection against hepatotoxicity
if given within 12 h of nonstaggered overdose [3].
Management of patients presenting within 24 h of
nonstaggered overdose is guided by the plasma
acetaminophen concentration, plotted against time since
ingestion on a treatment nomogram [3,4]. A number of
treatment nomograms are in use worldwide. All of these are
based on the Prescott nomogram, in which a line is drawn
that joins an acetaminophen concentration of 200 mg/l at 4 h
and one of 30 mg/l at 15 h (the ‘200-line’) [3]. The
nomograms are less reliable in patients who present late
(more than 15 h after ingestion), and patients with an
acetaminophen concentration just below the line should also
receive treatment [4,5].
The hepatotoxic dose of acetaminophen is generally
accepted to be 150 mg/kg [4,5], although the evidence for
this is far from strong [5]. We recommend that, regardless of
ingested dose, all patients presenting within 24 h of
nonstaggered acetaminophen overdose should have their
plasma acetaminophen concentration determined.
A lower treatment line (the ‘100-line’), which joins an
acetaminophen concentration of 100 mg/l at 4 h with one of
15 mg/l at 15 h, is widely used for patients in one of two
high-risk groups [4,5]: conditions that lead to decreased
hepatic glutathione (e.g. malnutrition and anorexia nervosa);
and circumstances that increase cytochrome p450
microenzyme activity (particularly cytochrome p450 isoforms
2E1, 1A2 and 3A4), such as regular use of enzyme-inducing
drugs (e.g. phenytoin and carbamazepine) and possibly
chronic ethanol excess. However, a critical review of the
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Abstract
Acetaminophen overdose is common and can result from deliberate/nonstaggered or accidental/
staggered ingestion. Patients presenting within 24 h of an acetaminophen overdose can safely be
managed on medical wards. Early management of nonstaggered overdose is guided by the plasma
acetaminophen concentration, whereas management of accidental/staggered ingestion is guided by
ingested dose. Ingested dose and time from ingestion to presentation are important prognostic factors
in accidental/staggered ingestion. Acetaminophen-induced acute liver failure (ALF) requires meticulous
supportive care in an intensive care unit (ICU), with early identification and transfer of patients who are
likely to require liver transplantation to a specialist liver centre. The modified King’s College Hospital
criteria (incorporating lactate into the traditional criteria) represent the best tool for identifying patients
who require transplantation.
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literature [6] did not support the view that chronic ethanol
excess increases the risk for hepatotoxicity after
acetaminophen overdose. The evidence for the 100-line is
largely based on case reports, and is best described as a
‘best guess’ [5]. Until further evidence becomes available,
however, we support the use of the 100-line in the
categories of patients described above because it provides a
safety margin in patients who may provide an unreliable
history or who may present late.
Where should patients with early
acetaminophen poisoning be managed?
Regardless of the ingested dose, within the first 24 h of
ingestion patients with acetaminophen poisoning do not
exhibit significant symptoms or signs other than vomiting.
Gyamlani and Parikh [7] recommended that patients with
deliberate acetaminophen poisoning be managed on medical
floors, but that patients with accidental ingestion and chronic
alcoholic persons require ICU admission. We would go one
step further and advise that all patients presenting within
24 h of acetaminophen overdose, without concomitant
poisoning, can safely be managed on medical wards or
emergency department observation wards; this is current
routine practice in the UK [8]. Conversely, patients with
acetaminophen-induced ALF require meticulous supportive
care in an ICU.
Accidental versus deliberate acetaminophen
overdose
In the series reported by Gyamlani and Parikh [7], 14% of
ingestions were accidental and 86% were deliberate. These
findings differ from those reported in other US series (65%
accidental/35% deliberate, reported from poisons centre
data [2]; 60% accidental/40% deliberate, reported from liver
unit data [9]), but are similar to findings reported in the UK
(16% accidental/84% deliberate [8]) and Denmark (15%
accidental/85% deliberate [9]).
The plasma acetaminophen concentration is not interpretable
in patients with staggered ingestion, and management is
guided by the dose ingested [5]. Ingestion of more than
150 mg/kg over 24 h (75 mg/kg over 24 h in high-risk
patients) requires treatment with NAC [4,5].
There are few published data on outcome and prognosis in
accidental/staggered poisoning. Gyamlani and Parikh [7]
reported that peak aminotransferase and International
Normalized Ratio were greater in patients with
accidental/staggered ingestion, and the two patients who
developed ALF presented after accidental/staggered
ingestion. However, no data are provided regarding relative
times of presentation or ingested dose in the accidental and
deliberate ingestion groups. Those findings are in contrast to
those of two recent UK series [8,10]. In the first (n = 160)
[8], 26 patients (16%) presented with staggered ingestion
(20 presented within 24 h of ingestion). Nine received NAC
and only three developed hepatotoxicity (all three presented
more than 24 h after ingestion). Of those three patients, one
died after developing ALF and the other two were discharged
with normal liver function within 72 h. In the second series
(n = 280) [10], 19 patients (6.8%) presented with staggered
ingestion (mean dose 240 mg/kg over 24 h, range
112–464 mg/kg over 24 h). A total of 17 received NAC and
five developed hepatotoxicity (four of these presented more
than 24 h after ingestion, and one at 18 h). All
aminotransferase/International Normalized Ratio
abnormalities resolved within 48 h, and none of the patients
developed ALF.
On the basis of these, albeit limited, data, the most important
prognostic factors in accidental/staggered ingestion are the
ingested dose and time to presentation. Presentation beyond
24 h is associated with increased risk for hepatotoxicity. This
is because by this time the active N-acetylbenzoquinoneimine
metabolite has formed, and once hepatic glutathione has
been depleted hepatocellular damage occurs.
Acute liver failure in acetaminophen
poisoning
Considering the number of acetaminophen overdoses that
occur, hepatotoxicity is uncommon; ALF occurs in only 0.6%
of UK hospital episodes [9]. The most sensitive prognostic
marker is prothrombin time (PT). Approximately 50% of
patients with a PT of 36 s at 36 h after ingestion will develop
ALF [11]. In our clinical experience, when PT starts to
improve, full recovery follows.
If hepatic damage is extensive, ALF ensues on days 4–5
[5,12]. Acetaminophen-induced ALF is a multisystem disorder,
with acute renal failure, hypotension, sepsis, coagulopathy,
encephalopathy and cerebral oedema [5,12]. Decisions about
management and prognosis must be made quickly in order to
allow transfer of patients to liver transplantation centres before
they deteriorate (Table 1) [13,14].
The role of NAC in late acetaminophen poisoning is
controversial. There are many theories regarding its potential
mechanisms (e.g. free radical scavenging, oxygen kinetics),
and clinical studies have yielded conflicting findings on its
efficacy [5]. Routine UK practice is to continue NAC infusion
at 150 mg/kg over 24 h until either PT improves or the
patient receives a liver transplant [4,14].
Patients with acetaminophen-induced ALF require ICU
admission for meticulous supportive care, and to monitor for
and manage further organ system involvement [12].
Hypotension is common and inotropic support with
noradrenaline (norepinephrine) or adrenaline (epinephrine) is
often required, and should be guided by invasive
haemodynamic monitoring after adequate fluid resuscitation
[12]. Continuous veno-venous haemofiltration with lactate-
free fluid is used in patients with acute renal failure [14].Critical Care    April 2002 Vol 6 No 2 Dargan and Jones
Cerebral oedema due to elevated intracranial pressure is a
common cause of death. Intracranial pressure should be
monitored in all patients who require mechanical ventilation,
particularly those who fulfil criteria for transplantation [12].
Mannitol and thiopentone are used in management of
cerebral oedema, to maintain intracranial pressure below
20 mmHg [12].
Liver transplantation and acetaminophen
poisoning
There are no standard selection criteria for transplantation
that are in use worldwide, but the King’s College Hospital
criteria (Table 2) are the most widely accepted [15]. Without
transplantation, less than 15% of patients who meet these
criteria survive [16]. However, up to 50% of patients who
meet transplant criteria are either too unwell for
transplantation or die before a graft becomes available [13].
The King’s College Hospital criteria have good specificity in
identifying patients with poor prognosis, but they are of low
sensitivity and may fail to identify a proportion of patients who
will die [13].
In one study [16], the Acute Physiology and Chronic Health
Evaluation II score correlated with mortality. Specialist liver
scores may be less familiar to those who work in general
ICUs, and the use of the Acute Physiology and Chronic
Health Evaluation II score may help in the early identification
of patients who require transplantation and may expedite
appropriate transfer to a liver center [16].
A recent study [14] suggested that an arterial lactate
concentration greater than 3.5 mmol/l early (4 h) after
admission to the liver unit, or greater than 3.0 mmol/l after
fluid resuscitation (12 h after admission) identifies patients
who are likely to die earlier, with predictive ability equivalent
to that of the King’s College Hospital criteria. The authors of
that study proposed modified King’s College Hospital criteria
(Table 2), in order to increase the sensitivity of the criteria
and the speed of identification of patients who require
transplantation.
Conclusion
Patients who present within 24 h of an acetaminophen
overdose can safely be managed on medical wards. The
management of nonstaggered ingestion is guided by the
plasma acetaminophen concentration, whereas management
of accidental/staggered ingestion is guided by the dose
ingested. Prognostic factors in accidental/staggered
overdose include dose ingested and time from ingestion to
presentation.
Acetaminophen-induced ALF requires meticulous supportive
care on an ICU, and rapid identification and transfer to a
specialist liver centre is required for those patients who will
die without liver transplantation. Recent evidence indicates
that the modified King’s College Hospital criteria represent
the best tool for identifying patients who require
transplantation.
Table 1
When to contact a specialist liver centre in patients with
acetaminophen-induced hepatotoxicity
Progressive coagulopathy: PT in seconds greater than the number of 
hours since ingestion (or if the INR is >2 at 24 h, >4 at 48 h, and 
>6 at 72 h)
Renal impairment (creatinine >200 µmol/l)
Hypoglycaemia
Metabolic acidosis (pH <7.35)
Hypotension despite fluid resuscitation
Encephalopathy
INR = International Normalized Ratio; PT = prothrombin time. 
Data from Bernal et al. [14].
Table 2
King’s College Hospital criteria for liver transplantation in acetaminophen-induced acute liver failure
Current criteria [11] Modified criteria [14]
List for transplantation if: Strongly consider listing for transplantation if: 
Arterial pH <7.3 after adequate fluid resuscitation Arterial blood lactate concentration >3.5 mmol/l after early fluid 
resuscitation
List for transplantation if all three of the following occur  List for transplantation if:
within a 24-h period: Arterial pH <7.3, or arterial blood lactate concentration >3.0 mmol/l 
• Creatinine >300 µmol/l after adequate fluid resuscitation
• PT >100 s (INR >6.5)
• Grade III/IV encephalopathy List for transplantation if all three of the following occur within a 
24-h period:
• Creatinine >300 µmol/l
• PT >100 s (INR >6.5)
• Grade III/IV encephalopathy
INR = International Normalized Ratio; PT = prothrombin time.Competing interests
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